John C. Mc Kew Lumos Pharma, Inc. (LUMO) insider trading activity

John C. Mc Kew is Chief Scientific Officer of LUMOS PHARMA, INC.. Currently has a direct ownership of 12,653 shares of LUMO, which is worth approximately $54,660. The most recent transaction as insider was on Aug 06, 2024, when has been sold 3,407 shares (Common Stock) at a price of $1.89 per share, resulting in proceeds of $6,439. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7K

0% 3M change

32.36% 12M change

Total Value Held $54,660

John C. McKew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 06 2024	SELL Open market or private sale	$6,439 $1.89 p/Share	3,407 Reduced 21.21%	12,653 Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$2,851 $1.79 p/Share	1,593 Reduced 9.02%	16,060 Common Stock
Apr 03 2024	SELL Open market or private sale	$6,132 $2.77 p/Share	2,214 Reduced 11.43%	17,153 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$2,942 $2.84 p/Share	1,036 Reduced 5.08%	19,367 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	$5,680 $2.84 p/Share	2,000 Added 8.93%	20,403 Common Stock
Feb 06 2024	SELL Open market or private sale	$1,327 $3.03 p/Share	438 Reduced 2.32%	18,403 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,101 $3.01 p/Share	366 Reduced 1.91%	18,841 Common Stock
Aug 02 2023	SELL Open market or private sale	$10,936 $3.21 p/Share	3,407 Reduced 15.41%	18,707 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$5,225 $3.28 p/Share	1,593 Reduced 6.72%	22,114 Common Stock
Apr 04 2023	SELL Open market or private sale	$7,239 $3.27 p/Share	2,214 Reduced 8.71%	23,207 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$3,429 $3.31 p/Share	1,036 Reduced 3.92%	25,421 Common Stock
Feb 02 2023	SELL Open market or private sale	$1,549 $3.53 p/Share	439 Reduced 1.63%	26,457 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$725 $3.52 p/Share	206 Reduced 0.76%	26,896 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	$7,040 $3.52 p/Share	2,000 Added 6.87%	27,102 Common Stock
Aug 02 2022	SELL Open market or private sale	$27,631 $8.11 p/Share	3,407 Reduced 12.16%	24,602 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$13,015 $8.17 p/Share	1,593 Reduced 5.38%	28,009 Common Stock
Jun 06 2022	SELL Open market or private sale	$1,288 $7.62 p/Share	169 Reduced 0.58%	29,102 Common Stock
Apr 05 2022	SELL Open market or private sale	$18,420 $8.32 p/Share	2,214 Reduced 7.03%	29,271 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$9,562 $9.23 p/Share	1,036 Reduced 3.19%	31,485 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$1,002 $10.02 p/Share	100 Reduced 0.31%	32,521 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	$15,030 $10.02 p/Share	1,500 Added 4.4%	32,621 Common Stock
Sep 08 2021	SELL Open market or private sale	$25,018 $11.3 p/Share	2,214 Reduced 6.66%	31,012 Common Stock
Aug 01 2021	BUY Grant, award, or other acquisition	-	20,000 Added 37.58%	33,226 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$12,691 $12.25 p/Share	1,036 Reduced 7.26%	13,226 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	1,078 Added 7.03%	14,262 Common Stock

JCM

John C. Mc Kew

Chief Scientific Officer

Austin, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUMO shares.

Notify only if

Value

Insider Trading

Get notified when an Lumos Pharma, Inc. insider buys or sells LUMO shares.

Notify only if

Operation

Value

Type

News

Receive news related to LUMOS PHARMA, INC.

Track Activities on LUMO

Account